发明授权
- 专利标题： PIM-3 kinase as a target for type 2 diabetes mellitus
- 专利标题（中）： PIM-3激酶作为2型糖尿病的靶标
-
申请号： US10348081申请日： 2003-01-21
-
公开(公告)号： US07227006B2公开(公告)日： 2007-06-05
- 发明人: Marcus Korn , Guenter Mueller , Rudolf Schneider , Georg Tschank
- 申请人： Marcus Korn , Guenter Mueller , Rudolf Schneider , Georg Tschank
- 申请人地址： DE Frankfurt
- 专利权人： Sanofi-Aventis Deutschland GmbH
- 当前专利权人： Sanofi-Aventis Deutschland GmbH
- 当前专利权人地址： DE Frankfurt
- 代理商 Mark C. Nelligan
- 优先权： EP02001401 20020119
- 主分类号： C07H21/04
- IPC分类号： C07H21/04 ; C12N5/00 ; C12P19/34
摘要：
The invention relates to isolated nucleic acid molecules and to host cells comprising such nucleic acid molecules. Moreover, the invention relates to a polypeptide having PIM-3 activity and having a definite amino acid sequence, as well as to the use of PIM-3 as a screening agent for identifying anti-type 2 diabetes mellitus drugs and for preparing a medicament for the treatment of insulin resistance or type 2 diabetes mellitus.
公开/授权文献
- US20040038246A1 PIM-3 kinase as a target for type 2 diabetes mellitus 公开/授权日：2004-02-26
信息查询
